Clinical TrialsSearch results
Number of results: 1048
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- Phase 2 Study of Applying Pediatric Regimens to Younger Adult Patients with BCR-ABL-Negative Acute Lymphoblastic Leukemia (JALSG ALL202-U)
- Acute lymphoblastic leukemia
- Japan Adult Leukemia Study Group
- 2005-08-17
Other
- Phase 2 study of imatinib-combined chemotherapy for newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia (JALSG Ph+ALL202)
- Acute lymphoblastic leukemia
- Japan Adult Leukemia Study Group
- 2005-08-17
Other
- Randomized Controlled Trial to Test Efficacy of High-Dose Methotrexate Consolidation Therapy for BCR-ABL-Negative Acute Lymphoblastic Leukemia in Adults (JALSG ALL202-O)
- Acute lymphoblastic leukemia
- Japan Adult Leukemia Study Group
- 2005-08-17
Recruiting
- Asia-wide Study for Acute Lymphoblastic Leukemia in Children with Down Syndrome
- Acute lymphoblastic leukemia in Down syndrome children
- Okamoto Yasuhiro
- 2019-03-29
Recruiting
- Phase II study of the combination of Ino with mini-hyper CVD as induction therapy in childhood and AYA patients with high-risk relapsed ALL
- Acute lymphoblastinc leukemia
- Yamamoto Shohei
- 2024-09-26
Other
- Investigational study for elderly acute myelocytic leukemia
- acute myelocytic leukemia
- Japan Adult Leukemia Study Group
- 2005-09-20
Other
- Randmized controlled trial to test set-therapy and individualized-therapy for elderly acute myelocytic leukemia
- acute myelocytic leukemia
- Japan Adult Leukemia Study Group
- 2005-09-20
Recruiting
- CBT-P3 study comparing CA/CY/TBI with vs without G-CSF priming
- Acute myelogenous leukemia or myelodysplastic syndrome
- Terakura Seitaro
- 2019-02-28
Other
- Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG) AML-05: A Multi-Center Phase II Study in Children with Newly Diagnosed Acute Myeloid Leukemia
- Acute Myeloid Leukemia
- Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG)
- 2006-11-01
Other
- Phase I Study of gemtuzumab ozogamicin in combination with cytarabinne and idarubicin as induction therapy for relapsed or refractory patients with acute myeloid leukemia.
- Acute Myeloid Leukemia
- Japan Adult Leukemia Study Group
- 2008-05-10